Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 21.98
(11.18%)
CNY 21.98
(11.18%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 117.6 Million CNY | -36.69% |
| 2022 | 185.76 Million CNY | 178.61% |
| 2021 | 66.67 Million CNY | 12.44% |
| 2020 | 59.3 Million CNY | 22.89% |
| 2019 | 48.25 Million CNY | -12.25% |
| 2018 | 54.99 Million CNY | 31.01% |
| 2017 | 41.97 Million CNY | -43.41% |
| 2016 | 74.17 Million CNY | -13.35% |
| 2015 | 85.6 Million CNY | 106.19% |
| 2014 | 41.51 Million CNY | 4.62% |
| 2013 | 39.68 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 99.67 Million CNY | -15.24% |
| 2024 Q2 | 112.27 Million CNY | 12.64% |
| 2024 Q3 | 123.18 Million CNY | 9.73% |
| 2023 Q3 | 86.23 Million CNY | -32.49% |
| 2023 Q1 | 150.55 Million CNY | -18.96% |
| 2023 Q4 | 117.6 Million CNY | 36.38% |
| 2023 FY | 117.6 Million CNY | -36.69% |
| 2023 Q2 | 127.73 Million CNY | -15.16% |
| 2022 Q3 | 111.22 Million CNY | -33.12% |
| 2022 FY | 185.76 Million CNY | 178.61% |
| 2022 Q1 | 62.51 Million CNY | -6.25% |
| 2022 Q4 | 185.76 Million CNY | 67.02% |
| 2022 Q2 | 166.31 Million CNY | 166.05% |
| 2021 FY | 66.67 Million CNY | 12.44% |
| 2021 Q4 | 66.67 Million CNY | 21.5% |
| 2021 Q3 | 54.87 Million CNY | -33.64% |
| 2021 Q2 | 82.69 Million CNY | 66.99% |
| 2021 Q1 | 49.52 Million CNY | -16.49% |
| 2020 Q3 | 44.52 Million CNY | -57.48% |
| 2020 Q4 | 59.3 Million CNY | 33.2% |
| 2020 Q1 | 43.87 Million CNY | -9.08% |
| 2020 FY | 59.3 Million CNY | 22.89% |
| 2020 Q2 | 104.7 Million CNY | 138.65% |
| 2019 Q2 | 43.88 Million CNY | 0.0% |
| 2019 Q3 | 48.19 Million CNY | 9.83% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 48.25 Million CNY | -12.25% |
| 2019 Q4 | 48.25 Million CNY | 0.12% |
| 2018 FY | 54.99 Million CNY | 31.01% |
| 2018 Q4 | 54.99 Million CNY | 0.0% |
| 2017 FY | 41.97 Million CNY | -43.41% |
| 2016 FY | 74.17 Million CNY | -13.35% |
| 2015 FY | 85.6 Million CNY | 106.19% |
| 2014 FY | 41.51 Million CNY | 4.62% |
| 2013 FY | 39.68 Million CNY | 0.0% |